Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-10

Clinical Trial Update: Pudendal Block Using Liposomal Bupivacaine vs. Standard Treatment During Sacrospinous Ligament Fixation [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing pudendal block with liposomal bupivacaine versus standard treatment during sacrospinous ligament fixation for vaginal prolapse.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Atlantic Health System | Conditions: Vaginal Prolapse | Phase 4 | Status: UNKNOWN